TSLA
Tesla
-- 439.650 NVDA
NVIDIA
-- 134.390 AMD
Advanced Micro Devices
-- 121.245 MU
Micron Technology
-- 87.820 QUBT
Quantum Computing
-- 18.860 
“SiteOne Therapeutics Announces a $100 Million Series C Fina...
“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead program. Simultaneously, SiteOne and Vertex collaborate on a different project targeting the NaV1.7 sodium channel. This complex relationship highlights the competitive yet interdependent landscape of ion channel drug research. Novo Holdings, having followed SiteOne since its inception, was encouraged to invest due to promising early data and the pathway to success demonstrated by Vertex.”
nfa
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment